Research and Markets (http://www.researchandmarkets.com/research/krs84x/medullary_thyroid)
has announced the addition of the "Medullary
Thyroid Cancer - Pipeline Review, H1 2014" report to their
This report provides comprehensive information on the therapeutic
development for Medullary Thyroid Cancer, complete with comparative
analysis at various stages, therapeutics assessment by drug target,
mechanism of action (MoA), route of administration (RoA) and molecule
type, along with latest updates, and featured news and press releases.
It also reviews key players involved in the therapeutic development for
Medullary Thyroid Cancer and special features on late-stage and
The report enhances decision making capabilities and help to create
effective counter srategies to gain competitive advantage. It
strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.
For more information visit http://www.researchandmarkets.com/research/krs84x/medullary_thyroid
[ Back To NFVZone's Homepage ]